The impact of epicardial adipose tissue and right ventricular hypertrophy on diastolic and global function of right ventricle in patients with metabolic syndrome E Sedaia, V Revenco, I Gutan, V Ochisor, A Vascenco European Heart Journal 41 (Supplement_2), ehaa946. 0905, 2020 | 3 | 2020 |
Catecholamine-induced cardiomyopathy in a patient with pheochromocytoma and polycystic kidney and liver disease: a case report E Sedaia, A Esanu, V Ivanov, C Dumanschi, A Moiseeva, M Abraș, ... European Heart Journal-Case Reports 3 (2), ytz062, 2019 | 3 | 2019 |
Does metabolic syndrome influence right ventricular diastolic function in patients with preserved left ventricular systolic function? E Sedaia, V Revenco, A Moiseeva European Journal of Heart Failure, 406-406, 2019 | 3 | 2019 |
The effect of the metabolic syndrome on right ventricular diastolic function E Sedaia MedEspera 7, 46-47, 2018 | 3 | 2018 |
Sindromul metabolic: abordare contemporană a problemei E Sedaia Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 54 (2), 109-113, 2017 | 3 | 2017 |
Right ventricular remodeling in metabolic syndrome E Sedaia MedEspera: The 5th International Medical Congress for Students and Young …, 2014 | 3 | 2014 |
The role of epicardial fat thickness and lipid profile in right ventricular remodeling in patients with metabolic syndrome E Sedaia, V Revenco, I Gutan, V Ochisor, A Vascenco Atherosclerosis 315, e202, 2020 | 2 | 2020 |
The role of epicardial fat thickness and other parameters of visceral adiposity in right ventricular diastolic function in patients with metabolic syndrome E Sedaia, V Revenco EUROPEAN HEART JOURNAL 40, 1554-1554, 2019 | 2 | 2019 |
Evaluation of visceral adiposity and right ventricle diastolic and global function in patients with metabolic syndrome E Sedaia Atherosclerosis 287, e138, 2019 | 2 | 2019 |
The influence of blood pressure values and other components of metabolic syndrome on right ventricle Tei index E Sedaia, V Revenco, A Esanu, V Ochisor Journal of Hypertension 37, e113, 2019 | 2 | 2019 |
Right ventricular involvement in patients with systemic arterial hypertension and preserved left ventricular systolic function E Sedaia, V Revenco Journal of Hypertension 37, e245, 2019 | 2 | 2019 |
Rolul indicelui adipozității viscerale la pacienții cu sindrom metabolic E Sedaia, V Zota, V Revenco Общественное здоровье, экономика и менеджмент в медицине, 57-60, 2019 | 2 | 2019 |
Indicii obezității viscerale la pacienții cu sindrom metabolic E Sedaia, I Guțan, V Revenco Общественное здоровье, экономика и менеджмент в медицине, 53-56, 2019 | 2 | 2019 |
Ţesutul adipos epicardic și riscul cardiovascular la pacienţii cu sindrom metabolic E Sedaia, V Revenco Sănătate Publică, Economie şi Management în Medicină 66 (2), 73-75, 2016 | 2 | 2016 |
The effects of long-term treatment with sympathetic nervous system blockers on diastolic function in patients with resistant hypertension and heart failure with preserved … A Moiseeva, A Carauş, N Ciobanu, V Moscalu, E Sedaia, A Surev, ... European Journal of Heart Failure, 511-512, 2019 | 1 | 2019 |
Combinații fixe de medicamente în continuum cardiovascular. A Moiseeva, A Carauş, E Sedaia, A Bîtca, M Carauş Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 58 (1), 167-171, 2018 | 1 | 2018 |
Rolul ecocardiografiei de stres în evaluarea viabilităţii miocardului E Sedaia, V Revenco Curierul Medical 57 (6), 55-58, 2014 | 1 | 2014 |
The exercise capacity in patients with metabolic syndrome, visceral obesity and right and left ventricular hypertrophy E Sedaia, V Ochisor, V Revenco Atherosclerosis 379, S140-S141, 2023 | | 2023 |
The exercise tolerance dependence on epicardial fat thickness, right ventricular hypertrophy and right ventricular global function in patients with metabolic syndrome E Sedaia, V Revenco, V Ochisor European Heart Journal 43 (Supplement_2), ehac544. 2415, 2022 | | 2022 |
The role of metabolic syndrome, visceral obesity and insulin resistance in right and left ventricular hypertrophy ES Sedaia, V Revenco, V Ochisor Atherosclerosis 355, 129, 2022 | | 2022 |